1. Home
  2. SDHC vs ONCY Comparison

SDHC vs ONCY Comparison

Compare SDHC & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Douglas Homes Corp.

SDHC

Smith Douglas Homes Corp.

HOLD

Current Price

$13.73

Market Cap

102.3M

Sector

N/A

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.02

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDHC
ONCY
Founded
2008
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.3M
94.0M
IPO Year
2023
2002

Fundamental Metrics

Financial Performance
Metric
SDHC
ONCY
Price
$13.73
$1.02
Analyst Decision
Hold
Strong Buy
Analyst Count
6
4
Target Price
$14.60
$7.33
AVG Volume (30 Days)
202.5K
831.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.19
N/A
Revenue
$971,116,000.00
N/A
Revenue This Year
$4.21
N/A
Revenue Next Year
$11.07
$2,505.00
P/E Ratio
$11.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.13
$0.33
52 Week High
$23.50
$1.51

Technical Indicators

Market Signals
Indicator
SDHC
ONCY
Relative Strength Index (RSI) 48.23 56.46
Support Level $11.18 $0.94
Resistance Level $14.49 $1.13
Average True Range (ATR) 0.77 0.08
MACD 0.32 0.02
Stochastic Oscillator 48.33 79.69

Price Performance

Historical Comparison
SDHC
ONCY

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corpis a builder of single-family homes in communities in certain markets in the southeastern and southern United States. The Company's homes and communities are targeted to first-time and empty-nest homebuyers. The Company currently operates in metropolitan Atlanta, Birmingham, Chattanooga, Central Georgia, Charlotte, Dallas-Fort Worth, Greenville, Alabama Gulf Coast, Huntsville, Nashville, Raleigh and Houston. Its operations are currently organized into ten geographical divisions which comprise two reportable segments. Its Southeast segment consists of its Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of its Alabama, Dallas-Fort Worth, Houston, Nashville, and Alabama Gulf Coast divisions.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: